カテゴリー： GlobalInfoResearch, 世界

腫瘍学小分子薬の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）

【英語タイトル】Global Oncology Small Molecule Drugs Market 2019 by Company, Regions, Type and Application, Forecast to 2024

GlobalInfoResearchが出版した調査資料（GIR9100188）・商品コード：GIR9100188
・発行会社（調査会社）：GlobalInfoResearch
・発行日：2019年10月10日（※2024年版があります。お問い合わせください）
・ページ数：118
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール
・調査対象地域：グローバル
・産業分野：医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥515,040見積依頼/購入/質問フォーム
Multi User（10名様閲覧用）USD5,220 ⇒換算￥772,560見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,030,080見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
本調査レポートは、腫瘍学小分子薬の世界市場について調べ、まとめました。種類別セグメントは、化学療法薬、免疫調節薬、標的療法薬、ホルモン療法、その他等、用途別セグメントは、血液がん、乳がん、胃腸がん、前立腺がん、肺がん、その他等に区分しました。腫瘍学小分子薬の世界市場概観、企業動向、企業別腫瘍学小分子薬シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。
・腫瘍学小分子薬の市場概観
・腫瘍学小分子薬の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等）
・腫瘍学小分子薬の企業別販売動向、市場シェア、市場集中度、競争動向
・腫瘍学小分子薬の世界市場規模
・腫瘍学小分子薬の北米市場分析（アメリカ、カナダ、メキシコ等）
・腫瘍学小分子薬のアメリカ市場規模推移
・腫瘍学小分子薬のカナダ市場規模推移
・腫瘍学小分子薬のメキシコ市場規模推移
・腫瘍学小分子薬のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）
・腫瘍学小分子薬のドイツ市場規模推移
・腫瘍学小分子薬のイギリス市場規模推移
・腫瘍学小分子薬のロシア市場規模推移
・腫瘍学小分子薬のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等）
・腫瘍学小分子薬の日本市場規模推移
・腫瘍学小分子薬の中国市場規模推移
・腫瘍学小分子薬の韓国市場規模推移
・腫瘍学小分子薬のインド市場規模推移
・腫瘍学小分子薬の東南アジア市場規模推移
・腫瘍学小分子薬の南米市場分析（ブラジル、アルゼンチン等）
・腫瘍学小分子薬の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等）
・腫瘍学小分子薬の種類別分析/販売量、売上、市場シェア（化学療法薬、免疫調節薬、標的療法薬、ホルモン療法、その他）
・腫瘍学小分子薬の用途別分析/市場規模（血液がん、乳がん、胃腸がん、前立腺がん、肺がん、その他）
・腫瘍学小分子薬の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測）
・腫瘍学小分子薬の販売チャネル・代理店・貿易業者・ディーラー分析
【レポートの概要】

Scope of the Report:
The global Oncology Small Molecule Drugs market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Oncology Small Molecule Drugs.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Oncology Small Molecule Drugs market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Oncology Small Molecule Drugs market by product type and applications/end industries.

Market Segment by Companies, this report covers
Johnson & Johnson
AbbVie
Celgene
Novartis
Roche
Pfizer
Takeda
Amgen
Bristol-Myers Squibb
Sanofi
Merck
Teva
Eli Lilly
Ipsen
Biogen Idec
Astellas
Bayer
Otsuka
Eisai
AstraZeneca
Gilead Sciences
Exelixis

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Chemotherapy Drugs
Immunomodulating Drugs
Targeted Therapy Drugs
Hormonal Therapy
Other

Market Segment by Applications, can be divided into
Blood Cancer
Breast Cancer
Gastrointestinal Cancer
Prostate Cancer
Lung Cancer
Other

【レポートの目次】

Table of Contents

1 Oncology Small Molecule Drugs Market Overview
1.1 Product Overview and Scope of Oncology Small Molecule Drugs
1.2 Classification of Oncology Small Molecule Drugs by Types
1.2.1 Global Oncology Small Molecule Drugs Revenue Comparison by Types (2019-2024)
1.2.2 Global Oncology Small Molecule Drugs Revenue Market Share by Types in 2018
1.2.3 Chemotherapy Drugs
1.2.4 Immunomodulating Drugs
1.2.5 Targeted Therapy Drugs
1.2.6 Hormonal Therapy
1.2.7 Other
1.3 Global Oncology Small Molecule Drugs Market by Application
1.3.1 Global Oncology Small Molecule Drugs Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Blood Cancer
1.3.3 Breast Cancer
1.3.4 Gastrointestinal Cancer
1.3.5 Prostate Cancer
1.3.6 Lung Cancer
1.3.7 Other
1.4 Global Oncology Small Molecule Drugs Market by Regions
1.4.1 Global Oncology Small Molecule Drugs Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Oncology Small Molecule Drugs Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Oncology Small Molecule Drugs Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Oncology Small Molecule Drugs Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Oncology Small Molecule Drugs Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Oncology Small Molecule Drugs Status and Prospect (2014-2024)
1.5 Global Market Size of Oncology Small Molecule Drugs (2014-2024)
2 Company Profiles
2.1 Johnson & Johnson
2.1.1 Business Overview
2.1.2 Oncology Small Molecule Drugs Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Johnson & Johnson Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.2 AbbVie
2.2.1 Business Overview
2.2.2 Oncology Small Molecule Drugs Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 AbbVie Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.3 Celgene
2.3.1 Business Overview
2.3.2 Oncology Small Molecule Drugs Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Celgene Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.4 Novartis
2.4.1 Business Overview
2.4.2 Oncology Small Molecule Drugs Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Novartis Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.5 Roche
2.5.1 Business Overview
2.5.2 Oncology Small Molecule Drugs Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Roche Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.6 Pfizer
2.6.1 Business Overview
2.6.2 Oncology Small Molecule Drugs Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Pfizer Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.7 Takeda
2.7.1 Business Overview
2.7.2 Oncology Small Molecule Drugs Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Takeda Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.8 Amgen
2.8.1 Business Overview
2.8.2 Oncology Small Molecule Drugs Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Amgen Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.9 Bristol-Myers Squibb
2.9.1 Business Overview
2.9.2 Oncology Small Molecule Drugs Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Bristol-Myers Squibb Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.10 Sanofi
2.10.1 Business Overview
2.10.2 Oncology Small Molecule Drugs Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Sanofi Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.11 Merck
2.11.1 Business Overview
2.11.2 Oncology Small Molecule Drugs Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Merck Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.12 Teva
2.12.1 Business Overview
2.12.2 Oncology Small Molecule Drugs Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Teva Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.13 Eli Lilly
2.13.1 Business Overview
2.13.2 Oncology Small Molecule Drugs Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Eli Lilly Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.14 Ipsen
2.14.1 Business Overview
2.14.2 Oncology Small Molecule Drugs Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Ipsen Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.15 Biogen Idec
2.15.1 Business Overview
2.15.2 Oncology Small Molecule Drugs Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Biogen Idec Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.16 Astellas
2.16.1 Business Overview
2.16.2 Oncology Small Molecule Drugs Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Astellas Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.17 Bayer
2.17.1 Business Overview
2.17.2 Oncology Small Molecule Drugs Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 Bayer Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.18 Otsuka
2.18.1 Business Overview
2.18.2 Oncology Small Molecule Drugs Type and Applications
2.18.2.1 Product A
2.18.2.2 Product B
2.18.3 Otsuka Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.19 Eisai
2.19.1 Business Overview
2.19.2 Oncology Small Molecule Drugs Type and Applications
2.19.2.1 Product A
2.19.2.2 Product B
2.19.3 Eisai Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.20 AstraZeneca
2.20.1 Business Overview
2.20.2 Oncology Small Molecule Drugs Type and Applications
2.20.2.1 Product A
2.20.2.2 Product B
2.20.3 AstraZeneca Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.21 Gilead Sciences
2.21.1 Business Overview
2.21.2 Oncology Small Molecule Drugs Type and Applications
2.21.2.1 Product A
2.21.2.2 Product B
2.21.3 Gilead Sciences Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.22 Exelixis
2.22.1 Business Overview
2.22.2 Oncology Small Molecule Drugs Type and Applications
2.22.2.1 Product A
2.22.2.2 Product B
2.22.3 Exelixis Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2017-2018)
3 Global Oncology Small Molecule Drugs Market Competition, by Players
3.1 Global Oncology Small Molecule Drugs Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Oncology Small Molecule Drugs Players Market Share
3.2.2 Top 10 Oncology Small Molecule Drugs Players Market Share
3.3 Market Competition Trend
4 Global Oncology Small Molecule Drugs Market Size by Regions
4.1 Global Oncology Small Molecule Drugs Revenue and Market Share by Regions
4.2 North America Oncology Small Molecule Drugs Revenue and Growth Rate (2014-2019)
4.3 Europe Oncology Small Molecule Drugs Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Oncology Small Molecule Drugs Revenue and Growth Rate (2014-2019)
4.5 South America Oncology Small Molecule Drugs Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Oncology Small Molecule Drugs Revenue and Growth Rate (2014-2019)
5 North America Oncology Small Molecule Drugs Revenue by Countries
5.1 North America Oncology Small Molecule Drugs Revenue by Countries (2014-2019)
5.2 USA Oncology Small Molecule Drugs Revenue and Growth Rate (2014-2019)
5.3 Canada Oncology Small Molecule Drugs Revenue and Growth Rate (2014-2019)
5.4 Mexico Oncology Small Molecule Drugs Revenue and Growth Rate (2014-2019)
6 Europe Oncology Small Molecule Drugs Revenue by Countries
6.1 Europe Oncology Small Molecule Drugs Revenue by Countries (2014-2019)
6.2 Germany Oncology Small Molecule Drugs Revenue and Growth Rate (2014-2019)
6.3 UK Oncology Small Molecule Drugs Revenue and Growth Rate (2014-2019)
6.4 France Oncology Small Molecule Drugs Revenue and Growth Rate (2014-2019)
6.5 Russia Oncology Small Molecule Drugs Revenue and Growth Rate (2014-2019)
6.6 Italy Oncology Small Molecule Drugs Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Oncology Small Molecule Drugs Revenue by Countries
7.1 Asia-Pacific Oncology Small Molecule Drugs Revenue by Countries (2014-2019)
7.2 China Oncology Small Molecule Drugs Revenue and Growth Rate (2014-2019)
7.3 Japan Oncology Small Molecule Drugs Revenue and Growth Rate (2014-2019)
7.4 Korea Oncology Small Molecule Drugs Revenue and Growth Rate (2014-2019)
7.5 India Oncology Small Molecule Drugs Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Oncology Small Molecule Drugs Revenue and Growth Rate (2014-2019)
8 South America Oncology Small Molecule Drugs Revenue by Countries
8.1 South America Oncology Small Molecule Drugs Revenue by Countries (2014-2019)
8.2 Brazil Oncology Small Molecule Drugs Revenue and Growth Rate (2014-2019)
8.3 Argentina Oncology Small Molecule Drugs Revenue and Growth Rate (2014-2019)
8.4 Colombia Oncology Small Molecule Drugs Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Oncology Small Molecule Drugs by Countries
9.1 Middle East and Africa Oncology Small Molecule Drugs Revenue by Countries (2014-2019)
9.2 Saudi Arabia Oncology Small Molecule Drugs Revenue and Growth Rate (2014-2019)
9.3 UAE Oncology Small Molecule Drugs Revenue and Growth Rate (2014-2019)
9.4 Egypt Oncology Small Molecule Drugs Revenue and Growth Rate (2014-2019)
9.5 Nigeria Oncology Small Molecule Drugs Revenue and Growth Rate (2014-2019)
9.6 South Africa Oncology Small Molecule Drugs Revenue and Growth Rate (2014-2019)
10 Global Oncology Small Molecule Drugs Market Segment by Type
10.1 Global Oncology Small Molecule Drugs Revenue and Market Share by Type (2014-2019)
10.2 Global Oncology Small Molecule Drugs Market Forecast by Type (2019-2024)
10.3 Chemotherapy Drugs Revenue Growth Rate (2014-2024)
10.4 Immunomodulating Drugs Revenue Growth Rate (2014-2024)
10.5 Targeted Therapy Drugs Revenue Growth Rate (2014-2024)
10.6 Hormonal Therapy Revenue Growth Rate (2014-2024)
10.7 Other Revenue Growth Rate (2014-2024)
11 Global Oncology Small Molecule Drugs Market Segment by Application
11.1 Global Oncology Small Molecule Drugs Revenue Market Share by Application (2014-2019)
11.2 Oncology Small Molecule Drugs Market Forecast by Application (2019-2024)
11.3 Blood Cancer Revenue Growth (2014-2019)
11.4 Breast Cancer Revenue Growth (2014-2019)
11.5 Gastrointestinal Cancer Revenue Growth (2014-2019)
11.6 Prostate Cancer Revenue Growth (2014-2019)
11.7 Lung Cancer Revenue Growth (2014-2019)
11.8 Other Revenue Growth (2014-2019)
12 Global Oncology Small Molecule Drugs Market Size Forecast (2019-2024)
12.1 Global Oncology Small Molecule Drugs Market Size Forecast (2019-2024)
12.2 Global Oncology Small Molecule Drugs Market Forecast by Regions (2019-2024)
12.3 North America Oncology Small Molecule Drugs Revenue Market Forecast (2019-2024)
12.4 Europe Oncology Small Molecule Drugs Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Oncology Small Molecule Drugs Revenue Market Forecast (2019-2024)
12.6 South America Oncology Small Molecule Drugs Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Oncology Small Molecule Drugs Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source

List of Tables and Figures

Figure Oncology Small Molecule Drugs Picture
Table Product Specifications of Oncology Small Molecule Drugs
Table Global Oncology Small Molecule Drugs and Revenue (Million USD) Market Split by Product Type
Figure Global Oncology Small Molecule Drugs Revenue Market Share by Types in 2018
Figure Chemotherapy Drugs Picture
Figure Immunomodulating Drugs Picture
Figure Targeted Therapy Drugs Picture
Figure Hormonal Therapy Picture
Figure Other Picture
Table Global Oncology Small Molecule Drugs Revenue (Million USD) by Application (2014-2024)
Figure Oncology Small Molecule Drugs Revenue Market Share by Applications in 2018
Figure Blood Cancer Picture
Figure Breast Cancer Picture
Figure Gastrointestinal Cancer Picture
Figure Prostate Cancer Picture
Figure Lung Cancer Picture
Figure Other Picture
Table Global Market Oncology Small Molecule Drugs Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Oncology Small Molecule Drugs Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Oncology Small Molecule Drugs Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Oncology Small Molecule Drugs Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Oncology Small Molecule Drugs Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Oncology Small Molecule Drugs Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Oncology Small Molecule Drugs Revenue (Million USD) and Growth Rate (2014-2024)
Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table Johnson & Johnson Oncology Small Molecule Drugs Type and Applications
Table Johnson & Johnson Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table AbbVie Basic Information, Manufacturing Base and Competitors
Table AbbVie Oncology Small Molecule Drugs Type and Applications
Table AbbVie Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Celgene Basic Information, Manufacturing Base and Competitors
Table Celgene Oncology Small Molecule Drugs Type and Applications
Table Celgene Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Oncology Small Molecule Drugs Type and Applications
Table Novartis Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Roche Basic Information, Manufacturing Base and Competitors
Table Roche Oncology Small Molecule Drugs Type and Applications
Table Roche Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Oncology Small Molecule Drugs Type and Applications
Table Pfizer Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Takeda Basic Information, Manufacturing Base and Competitors
Table Takeda Oncology Small Molecule Drugs Type and Applications
Table Takeda Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Amgen Basic Information, Manufacturing Base and Competitors
Table Amgen Oncology Small Molecule Drugs Type and Applications
Table Amgen Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table Bristol-Myers Squibb Oncology Small Molecule Drugs Type and Applications
Table Bristol-Myers Squibb Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Sanofi Basic Information, Manufacturing Base and Competitors
Table Sanofi Oncology Small Molecule Drugs Type and Applications
Table Sanofi Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Oncology Small Molecule Drugs Type and Applications
Table Merck Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Teva Basic Information, Manufacturing Base and Competitors
Table Teva Oncology Small Molecule Drugs Type and Applications
Table Teva Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Eli Lilly Basic Information, Manufacturing Base and Competitors
Table Eli Lilly Oncology Small Molecule Drugs Type and Applications
Table Eli Lilly Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Ipsen Basic Information, Manufacturing Base and Competitors
Table Ipsen Oncology Small Molecule Drugs Type and Applications
Table Ipsen Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Biogen Idec Basic Information, Manufacturing Base and Competitors
Table Biogen Idec Oncology Small Molecule Drugs Type and Applications
Table Biogen Idec Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Astellas Basic Information, Manufacturing Base and Competitors
Table Astellas Oncology Small Molecule Drugs Type and Applications
Table Astellas Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Bayer Basic Information, Manufacturing Base and Competitors
Table Bayer Oncology Small Molecule Drugs Type and Applications
Table Bayer Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Otsuka Basic Information, Manufacturing Base and Competitors
Table Otsuka Oncology Small Molecule Drugs Type and Applications
Table Otsuka Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Eisai Basic Information, Manufacturing Base and Competitors
Table Eisai Oncology Small Molecule Drugs Type and Applications
Table Eisai Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table AstraZeneca Basic Information, Manufacturing Base and Competitors
Table AstraZeneca Oncology Small Molecule Drugs Type and Applications
Table AstraZeneca Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Gilead Sciences Basic Information, Manufacturing Base and Competitors
Table Gilead Sciences Oncology Small Molecule Drugs Type and Applications
Table Gilead Sciences Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Exelixis Basic Information, Manufacturing Base and Competitors
Table Exelixis Oncology Small Molecule Drugs Type and Applications
Table Exelixis Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Global Oncology Small Molecule Drugs Revenue (Million USD) by Players (2014-2019)
Table Global Oncology Small Molecule Drugs Revenue Share by Players (2014-2019)
Figure Global Oncology Small Molecule Drugs Revenue Share by Players in 2017
Figure Global Oncology Small Molecule Drugs Revenue Share by Players in 2018
Figure Global Top 5 Players Oncology Small Molecule Drugs Revenue Market Share in 2018
Figure Global Top 10 Players Oncology Small Molecule Drugs Revenue Market Share in 2018
Figure Global Oncology Small Molecule Drugs Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Oncology Small Molecule Drugs Revenue (Million USD) by Regions (2014-2019)
Table Global Oncology Small Molecule Drugs Revenue Market Share by Regions (2014-2019)
Figure Global Oncology Small Molecule Drugs Revenue Market Share by Regions (2014-2019)
Figure Global Oncology Small Molecule Drugs Revenue Market Share by Regions in 2018
Figure North America Oncology Small Molecule Drugs Revenue and Growth Rate (2014-2019)
Figure Europe Oncology Small Molecule Drugs Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Oncology Small Molecule Drugs Revenue and Growth Rate (2014-2019)
Figure South America Oncology Small Molecule Drugs Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Oncology Small Molecule Drugs Revenue and Growth Rate (2014-2019)
Table North America Oncology Small Molecule Drugs Revenue by Countries (2014-2019)
Table North America Oncology Small Molecule Drugs Revenue Market Share by Countries (2014-2019)
Figure North America Oncology Small Molecule Drugs Revenue Market Share by Countries (2014-2019)
Figure North America Oncology Small Molecule Drugs Revenue Market Share by Countries in 2018
Figure USA Oncology Small Molecule Drugs Revenue and Growth Rate (2014-2019)
Figure Canada Oncology Small Molecule Drugs Revenue and Growth Rate (2014-2019)
Figure Mexico Oncology Small Molecule Drugs Revenue and Growth Rate (2014-2019)
Table Europe Oncology Small Molecule Drugs Revenue (Million USD) by Countries (2014-2019)
Figure Europe Oncology Small Molecule Drugs Revenue Market Share by Countries (2014-2019)
Figure Europe Oncology Small Molecule Drugs Revenue Market Share by Countries in 2018
Figure Germany Oncology Small Molecule Drugs Revenue and Growth Rate (2014-2019)
Figure UK Oncology Small Molecule Drugs Revenue and Growth Rate (2014-2019)
Figure France Oncology Small Molecule Drugs Revenue and Growth Rate (2014-2019)
Figure Russia Oncology Small Molecule Drugs Revenue and Growth Rate (2014-2019)
Figure Italy Oncology Small Molecule Drugs Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Oncology Small Molecule Drugs Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Oncology Small Molecule Drugs Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Oncology Small Molecule Drugs Revenue Market Share by Countries in 2018
Figure China Oncology Small Molecule Drugs Revenue and Growth Rate (2014-2019)
Figure Japan Oncology Small Molecule Drugs Revenue and Growth Rate (2014-2019)
Figure Korea Oncology Small Molecule Drugs Revenue and Growth Rate (2014-2019)
Figure India Oncology Small Molecule Drugs Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Oncology Small Molecule Drugs Revenue and Growth Rate (2014-2019)
Table South America Oncology Small Molecule Drugs Revenue by Countries (2014-2019)
Table South America Oncology Small Molecule Drugs Revenue Market Share by Countries (2014-2019)
Figure South America Oncology Small Molecule Drugs Revenue Market Share by Countries (2014-2019)
Figure South America Oncology Small Molecule Drugs Revenue Market Share by Countries in 2018
Figure Brazil Oncology Small Molecule Drugs Revenue and Growth Rate (2014-2019)
Figure Argentina Oncology Small Molecule Drugs Revenue and Growth Rate (2014-2019)
Figure Colombia Oncology Small Molecule Drugs Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Oncology Small Molecule Drugs Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Oncology Small Molecule Drugs Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Oncology Small Molecule Drugs Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Oncology Small Molecule Drugs Revenue Market Share by Countries in 2018
Figure Saudi Arabia Oncology Small Molecule Drugs Revenue and Growth Rate (2014-2019)
Figure UAE Oncology Small Molecule Drugs Revenue and Growth Rate (2014-2019)
Figure Egypt Oncology Small Molecule Drugs Revenue and Growth Rate (2014-2019)
Figure Nigeria Oncology Small Molecule Drugs Revenue and Growth Rate (2014-2019)
Figure South Africa Oncology Small Molecule Drugs Revenue and Growth Rate (2014-2019)
Table Global Oncology Small Molecule Drugs Revenue (Million USD) by Type (2014-2019)
Table Global Oncology Small Molecule Drugs Revenue Share by Type (2014-2019)
Figure Global Oncology Small Molecule Drugs Revenue Share by Type (2014-2019)
Figure Global Oncology Small Molecule Drugs Revenue Share by Type in 2018
Table Global Oncology Small Molecule Drugs Revenue Forecast by Type (2019-2024)
Figure Global Oncology Small Molecule Drugs Market Share Forecast by Type (2019-2024)
Figure Global Chemotherapy Drugs Revenue Growth Rate (2014-2019)
Figure Global Immunomodulating Drugs Revenue Growth Rate (2014-2019)
Figure Global Targeted Therapy Drugs Revenue Growth Rate (2014-2019)
Figure Global Hormonal Therapy Revenue Growth Rate (2014-2019)
Figure Global Other Revenue Growth Rate (2014-2019)
Table Global Oncology Small Molecule Drugs Revenue by Application (2014-2019)
Table Global Oncology Small Molecule Drugs Revenue Share by Application (2014-2019)
Figure Global Oncology Small Molecule Drugs Revenue Share by Application (2014-2019)
Figure Global Oncology Small Molecule Drugs Revenue Share by Application in 2018
Table Global Oncology Small Molecule Drugs Revenue Forecast by Application (2019-2024)
Figure Global Oncology Small Molecule Drugs Market Share Forecast by Application (2019-2024)
Figure Global Blood Cancer Revenue Growth Rate (2014-2019)
Figure Global Breast Cancer Revenue Growth Rate (2014-2019)
Figure Global Gastrointestinal Cancer Revenue Growth Rate (2014-2019)
Figure Global Prostate Cancer Revenue Growth Rate (2014-2019)
Figure Global Lung Cancer Revenue Growth Rate (2014-2019)
Figure Global Other Revenue Growth Rate (2014-2019)
Figure Global Oncology Small Molecule Drugs Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Oncology Small Molecule Drugs Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Oncology Small Molecule Drugs Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Oncology Small Molecule Drugs Revenue Market Forecast (2019-2024)
Figure Europe Oncology Small Molecule Drugs Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Oncology Small Molecule Drugs Revenue Market Forecast (2019-2024)
Figure South America Oncology Small Molecule Drugs Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Oncology Small Molecule Drugs Revenue Market Forecast (2019-2024)


【掲載企業】

Johnson & Johnson、 AbbVie、 Celgene、 Novartis、 Roche、 Pfizer、 Takeda、 Amgen、 Bristol-Myers Squibb、 Sanofi、 Merck、 Teva、 Eli Lilly、 Ipsen、 Biogen Idec、 Astellas、 Bayer、 Otsuka、 Eisai、 AstraZeneca、 Gilead Sciences、 Exelixis

★調査レポート[腫瘍学小分子薬の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）] (コード：GIR9100188)販売に関する免責事項を必ずご確認ください。
★調査レポート[腫瘍学小分子薬の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 免疫腫瘍学アッセイの世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）
    GIR9101377 / GlobalInfoResearch / 2019年9月11日 / 本調査レポートは、免疫腫瘍学アッセイの世界市場について調べ、まとめました。種類別セグメントは、イムノアッセイ、フローサイトメトリー、PCR、次世代シーケンシング等、用途別セグメントは、研究、臨床診断等に区分しました。免疫腫瘍学アッセイの世界市場概観、企業動向、企業別免疫腫瘍学アッセイシェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・免疫腫瘍学アッセイの市場概観 ・免疫腫瘍学アッセイの企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・免疫腫瘍学アッセイの企業別販売動向、市場シェア、市場集中度、競争動向 ・免疫腫瘍学アッセイの世界市場規模 ・免疫腫瘍学アッセイの北米市場分析（アメリカ、カナダ、メキシコ等） ・免疫腫瘍学アッセイのアメリカ市場規模推移 ・免疫腫瘍学アッセイのカナダ市場規模推移 ・免疫腫瘍学アッセイのメキシコ市場規模推移 ・免疫腫瘍学アッセイのヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...Immuno-Oncology Assays Accelerate Cancer Immunotherapy enable fast, effective, and clinically relevant understanding of immuno-oncology targets, pathways and mechanisms, enabling quicker development of immuno-oncology drugs. Learn how you can rapidly screen and develop antibodies targeting checkpoint receptors, bi-specific antibodies, small molecules, or cellular therapies such as chimeric antigen receptor T-cells (CAR-T). Scope of the Report: The global Immuno Oncology Assays market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in...
  • 腫瘍学における遺伝子治療の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）
    GIR9100702 / GlobalInfoResearch / 2019年9月5日 / 本調査レポートは、腫瘍学における遺伝子治療の世界市場について調べ、まとめました。種類別セグメントは、生体外、生体内等、用途別セグメントは、病院、診断センター、研究所等に区分しました。腫瘍学における遺伝子治療の世界市場概観、企業動向、企業別腫瘍学における遺伝子治療シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・腫瘍学における遺伝子治療の市場概観 ・腫瘍学における遺伝子治療の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・腫瘍学における遺伝子治療の企業別販売動向、市場シェア、市場集中度、競争動向 ・腫瘍学における遺伝子治療の世界市場規模 ・腫瘍学における遺伝子治療の北米市場分析（アメリカ、カナダ、メキシコ等） ・腫瘍学における遺伝子治療のアメリカ市場規模推移 ・腫瘍学における遺伝子治療のカナダ市場規模推移 ・腫瘍学における遺伝子治療のメキシコ市場規模推移 ・腫瘍学における遺伝子治療のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...Gene therapy refers to any procedure that aims to treat or alleviate a disease by genetically modifying the cell of a patient.  Scope of the Report: The global Gene Therapy in Oncology market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions. North America, especially The United States, will still play an important role which cannot...
  • 神経芽腫薬の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）
    GIR9102908 / GlobalInfoResearch / 2019年9月23日 / 本調査レポートは、神経芽腫薬の世界市場について調べ、まとめました。種類別セグメントは、化学療法、免疫療法、その他等、用途別セグメントは、病院、診療所、その他等に区分しました。神経芽腫薬の世界市場概観、企業動向、企業別神経芽腫薬シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・神経芽腫薬の市場概観 ・神経芽腫薬の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・神経芽腫薬の企業別販売動向、市場シェア、市場集中度、競争動向 ・神経芽腫薬の世界市場規模 ・神経芽腫薬の北米市場分析（アメリカ、カナダ、メキシコ等） ・神経芽腫薬のアメリカ市場規模推移 ・神経芽腫薬のカナダ市場規模推移 ・神経芽腫薬のメキシコ市場規模推移 ・神経芽腫薬のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...Neuroblastoma (NB) is a type of cancer that forms in certain types of nerve tissue. It most frequently starts from one of the adrenal glands, but can also develop in the neck, chest, abdomen, or spine. Symptoms may include bone pain, a lump in the abdomen, neck, or chest, or a painless bluish lump under the skin. Scope of the Report: The global Neuroblastoma Drugs market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will...
  • 婦人科薬の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）
    GIR9103384 / GlobalInfoResearch / 2019年9月26日 / 本調査レポートは、婦人科薬の世界市場について調べ、まとめました。種類別セグメントは、ホルモン療法、非ホルモン療法等、用途別セグメントは、病院薬局、小売薬局、オンライン薬局等に区分しました。婦人科薬の世界市場概観、企業動向、企業別婦人科薬シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・婦人科薬の市場概観 ・婦人科薬の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・婦人科薬の企業別販売動向、市場シェア、市場集中度、競争動向 ・婦人科薬の世界市場規模 ・婦人科薬の北米市場分析（アメリカ、カナダ、メキシコ等） ・婦人科薬のアメリカ市場規模推移 ・婦人科薬のカナダ市場規模推移 ・婦人科薬のメキシコ市場規模推移 ・婦人科薬のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）... Scope of the Report: The global Gynecology Drugs market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions. North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Gynecology Drugs. Europe also play important roles in global market,...

    • ◆H&Iグローバルリサーチのお客様（例）◆